JP2023526590A5 - - Google Patents
Info
- Publication number
- JP2023526590A5 JP2023526590A5 JP2022569031A JP2022569031A JP2023526590A5 JP 2023526590 A5 JP2023526590 A5 JP 2023526590A5 JP 2022569031 A JP2022569031 A JP 2022569031A JP 2022569031 A JP2022569031 A JP 2022569031A JP 2023526590 A5 JP2023526590 A5 JP 2023526590A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063025955P | 2020-05-15 | 2020-05-15 | |
| US63/025,955 | 2020-05-15 | ||
| PCT/US2021/032434 WO2021231851A1 (en) | 2020-05-15 | 2021-05-14 | Methods and compositions for treating anemia using actriib ligand traps and mtor inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023526590A JP2023526590A (ja) | 2023-06-22 |
| JPWO2021231851A5 JPWO2021231851A5 (https=) | 2024-05-22 |
| JP2023526590A5 true JP2023526590A5 (https=) | 2024-05-22 |
Family
ID=78525025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569031A Pending JP2023526590A (ja) | 2020-05-15 | 2021-05-14 | ＡｃｔＲＩＩＢリガンドトラップ及びｍＴＯＲ阻害剤を使用して貧血を治療するための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230210827A1 (https=) |
| EP (2) | EP4149441A4 (https=) |
| JP (1) | JP2023526590A (https=) |
| KR (1) | KR20230010641A (https=) |
| CN (1) | CN115551487A (https=) |
| AU (1) | AU2021273065A1 (https=) |
| BR (1) | BR112022022830A2 (https=) |
| CA (1) | CA3177632A1 (https=) |
| IL (1) | IL298156A (https=) |
| MX (1) | MX2022014080A (https=) |
| WO (1) | WO2021231851A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41052A (fr) | 2014-10-09 | 2017-08-15 | Celgene Corp | Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii |
| US12186370B1 (en) | 2020-11-05 | 2025-01-07 | Celgene Corporation | ACTRIIB ligand trap compositions and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5561138A (en) * | 1994-12-13 | 1996-10-01 | American Home Products Corporation | Method of treating anemia |
| EP1771470B1 (en) | 2004-07-23 | 2013-06-26 | Acceleron Pharma Inc. | Actrii receptor polypeptides, methods and compositions |
| TWI782836B (zh) | 2007-02-02 | 2022-11-01 | 美商艾瑟勒朗法瑪公司 | 衍生自ActRIIB的變體與其用途 |
| SMT202300222T1 (it) | 2008-08-14 | 2023-09-06 | Acceleron Pharma Inc | Trappole di gdf |
| CN104968801B (zh) | 2012-10-24 | 2021-06-15 | 细胞基因公司 | 用于治疗贫血症的生物标志物 |
| MA41119A (fr) * | 2014-12-03 | 2017-10-10 | Acceleron Pharma Inc | Méthodes de traitement de syndromes myélodysplasiques et d'anémie sidéroblastique |
| IL258574B2 (en) * | 2015-11-11 | 2025-01-01 | Novartis Ag | Uses of myostatin antagonists, combinations containing them and their uses |
| PL3490582T3 (pl) * | 2016-07-27 | 2024-09-23 | Acceleron Pharma Inc. | Kompozycje do zastosowania w leczeniu mielofibrozy |
| WO2018185341A1 (en) * | 2017-04-07 | 2018-10-11 | Ospedale San Raffaele S.R.L. | Regulator of bmp-smad signaling and uses thereof |
| HRP20241477T1 (hr) * | 2017-06-14 | 2025-01-03 | Celgene Corporation | Postupci liječenja mijeloproliferativne neoplazme povezane s mijelofibrozom i anemijom |
| US20220372136A1 (en) * | 2019-09-27 | 2022-11-24 | Disc Medicine, Inc. | Methods for treating anemia of chronic disease |
-
2021
- 2021-05-14 CA CA3177632A patent/CA3177632A1/en active Pending
- 2021-05-14 CN CN202180034458.7A patent/CN115551487A/zh active Pending
- 2021-05-14 BR BR112022022830A patent/BR112022022830A2/pt unknown
- 2021-05-14 AU AU2021273065A patent/AU2021273065A1/en active Pending
- 2021-05-14 EP EP21803281.1A patent/EP4149441A4/en not_active Withdrawn
- 2021-05-14 IL IL298156A patent/IL298156A/en unknown
- 2021-05-14 KR KR1020227039375A patent/KR20230010641A/ko active Pending
- 2021-05-14 JP JP2022569031A patent/JP2023526590A/ja active Pending
- 2021-05-14 MX MX2022014080A patent/MX2022014080A/es unknown
- 2021-05-14 WO PCT/US2021/032434 patent/WO2021231851A1/en not_active Ceased
- 2021-05-14 US US17/924,821 patent/US20230210827A1/en active Pending
- 2021-05-14 EP EP25203135.6A patent/EP4649961A3/en active Pending